| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/08/2001 | CA2382345A1 Extended duration light activated cancer therapy |
| 03/08/2001 | CA2381813A1 Treatment of fungal infections utilizing a fungal growth medium |
| 03/08/2001 | CA2353531A1 Nitric oxide-producing hydrogel materials |
| 03/07/2001 | EP1080733A1 Solid preparations for oral administration of drugs relating to genes |
| 03/07/2001 | EP1080732A1 Drug composites |
| 03/07/2001 | EP1080731A2 Composition and device structure for iontophoresis |
| 03/07/2001 | EP1080721A2 Non-crystalline solid dispersant comprising cefuromixe axetil |
| 03/07/2001 | EP1080719A2 Methods for potentiation of efficacy of topical actives by mono-acyl-(lyso)-glycerophosholipids |
| 03/07/2001 | EP1080718A1 Composition for sustained release of human growth hormone |
| 03/07/2001 | EP1080714A2 Detergent compositions with enhanced depositing, conditioning and softness capabilities |
| 03/07/2001 | EP1080226A1 Compositions and methods for topical delivery of oligonucleotides |
| 03/07/2001 | EP1080202A2 Convection-enhanced delivery of aav vectors |
| 03/07/2001 | EP1080193A2 Multivalent t cell receptor complexes |
| 03/07/2001 | EP1080103A1 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1079862A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody |
| 03/07/2001 | EP1079859A1 Bifunctional molecules and therapies based thereon |
| 03/07/2001 | EP1079850A1 Compound delivery using rapidly dissolving collagen film |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079842A1 Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases |
| 03/07/2001 | EP1079838A1 Edelfosin for the treatment of brain tumours |
| 03/07/2001 | EP1079834A1 Stabile compositions comprising levosimendan and alginic acid |
| 03/07/2001 | EP1079832A1 Use of vitamin pp compounds |
| 03/07/2001 | EP1079823A1 Compositions comprising organic mono- or dinitrate for treating impotence |
| 03/07/2001 | EP1079822A1 Composition containing polyacrylate, polyterpene, nitroglycerine and possibly polyvinyl acetate |
| 03/07/2001 | EP1079814A1 Layering process and apparatus therefor |
| 03/07/2001 | EP1079813A2 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
| 03/07/2001 | EP1079812A1 Novel particulate formulations |
| 03/07/2001 | EP1079811A1 Biodegradable sustained-release alginate gels |
| 03/07/2001 | EP1079809A1 Enteric coated pharmaceutical composition and method of manufacturing |
| 03/07/2001 | EP1079808A1 Thermoprotected microparticle compositions and process for terminal steam sterilization thereof |
| 03/07/2001 | EP1079805A1 Pharmaceutical composition comprising factor viii and neutral liposomes |
| 03/07/2001 | EP1079804A1 Pharmaceutical compositions comprising an amphoteric surfactant an alkoxylated cetyl alcohol and a polar drug |
| 03/07/2001 | EP1079803A2 Protein formulations |
| 03/07/2001 | EP0486526B2 Tumour necrosis factor binding ligands |
| 03/07/2001 | CN1286631A Tablets quickly disintegrating in oral cavity and process for producing same |
| 03/07/2001 | CN1286629A 片剂组合物 Tablet composition |
| 03/07/2001 | CN1062770C Vaccine both for hepatitis A and measles, and production method therefor |
| 03/07/2001 | CN1062733C Liposome preparing process and preparation |
| 03/06/2001 | US6197934 Compound delivery using rapidly dissolving collagen film |
| 03/06/2001 | US6197828 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 03/06/2001 | US6197813 At least one aldonic compound, a water-soluble zinc salt. |
| 03/06/2001 | US6197801 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 03/06/2001 | US6197787 Pharmaceutical formulations containing poorly soluble drug substances |
| 03/06/2001 | US6197781 Spray drying mixture of rapamycin suspension and carrier |
| 03/06/2001 | US6197764 Clozapine compositions and uses thereof |
| 03/06/2001 | US6197758 Methods for supplying postgastrectomic mineral and methods for treating postgastrectomic syndrome |
| 03/06/2001 | US6197754 Tyrosine kinase inhibitor |
| 03/06/2001 | US6197749 Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes |
| 03/06/2001 | US6197746 Method of using secretin for treating autism |
| 03/06/2001 | US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor |
| 03/06/2001 | US6197528 Composition of immunotoxins and retinoids and use thereof |
| 03/06/2001 | US6197351 Treatment of endometrial mucosa of uterus tissues |
| 03/06/2001 | US6197348 Taste masked liquid suspensions |
| 03/06/2001 | US6197346 Administering to mucous membranes of patients |
| 03/06/2001 | US6197344 Butorphanol sustained release formulations |
| 03/06/2001 | US6197342 Impregnation of a biological active ceramic or glass |
| 03/06/2001 | US6197340 Controlled release lipoic acid |
| 03/06/2001 | US6197335 Dissolving cyclosporins with anionic surfactants |
| 03/06/2001 | US6197333 Materials and methods for making improved liposome compositions |
| 03/06/2001 | US6197332 Lipid-conjugated polyamide compounds and related compositions and methods thereof |
| 03/06/2001 | US6197329 Anti-nausea compositions and methods |
| 03/06/2001 | US6197328 Nasally administrable compositions |
| 03/06/2001 | US6197325 Supplemented and unsupplemented tissue sealants, methods of their production and use |
| 03/06/2001 | US6197323 Medicinal preparation containing a lipophilic inert gas |
| 03/06/2001 | US6197318 Containing xyloglucan |
| 03/06/2001 | US6197317 Composition and method for the treatment of skin |
| 03/06/2001 | US6197302 Administering fusion protein of major histocompatibility complex complexed to immunoglobulin constant domain |
| 03/06/2001 | US6197293 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 03/06/2001 | US6197290 Anion exchange resin-containing tablets |
| 03/06/2001 | US6197283 Using without emulsions as thickeners in cosmetic and pharmaceutical formulations |
| 03/06/2001 | US6197279 Methods of delivering oxygen with emulsions |
| 03/06/2001 | US6197229 Primary emulsion is formed which optionally contains a dna nicking inhibitor in addition to dna with or without buffer, temperature of the primary emulsion is lowered below the freezing point of the aqueous inner phase |
| 03/06/2001 | CA1341198C Monoclonal antibodies against melanoma-associated antigens, hybrid cell lines producing these antibodies, and use therefor |
| 03/02/2001 | CA2316764A1 Food using y-aminobutyric acid-enriched cruciferous plant |
| 03/01/2001 | WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 03/01/2001 | WO2001014411A1 Recombinant subunit vaccine |
| 03/01/2001 | WO2001014395A2 Novel glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
| 03/01/2001 | WO2001014367A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | WO2001014326A1 Branched, largely unsaturated fatty alcohol ether sulphates |
| 03/01/2001 | WO2001014325A2 Branched, substantially unsaturated fatty alcohol sulfates |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001014309A1 Branched, substantially unsaturated ester oils |
| 03/01/2001 | WO2001014301A1 Branched, largely unsaturated fatty alcohol polyglycolethers |
| 03/01/2001 | WO2001013968A1 Cyclodextrin containing pressure sensitive adhesives |
| 03/01/2001 | WO2001013967A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | WO2001013960A1 Methods for in vivo gene delivery to sites of cartilage damage |
| 03/01/2001 | WO2001013958A2 Drug conjugates and methods of designing the same |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013956A2 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | WO2001013955A1 Film forming polymers, methods of use, and devices and applications thereof |
| 03/01/2001 | WO2001013954A1 Method of treating body insect infestation |
| 03/01/2001 | WO2001013950A1 Percutaneous absorption agents |
| 03/01/2001 | WO2001013938A1 Medicinal composition for percutaneous/permucosal absorption |
| 03/01/2001 | WO2001013927A2 Improved topical compositions containing probiotic bacteria, spores, and extracellular products and uses thereof |
| 03/01/2001 | WO2001013924A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | WO2001013914A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 03/01/2001 | WO2001013913A1 Compositions containing esters for treating parasitic infestations of organisms |
| 03/01/2001 | WO2001013906A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | WO2001013897A1 Oral liquid compositions |